TIBERTI, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 3.181
EU - Europa 1.384
AS - Asia 1.288
SA - Sud America 210
AF - Africa 49
OC - Oceania 6
Totale 6.118
Nazione #
US - Stati Uniti d'America 3.143
SG - Singapore 582
IT - Italia 462
HK - Hong Kong 260
DE - Germania 207
BR - Brasile 180
IN - India 179
SE - Svezia 155
CN - Cina 148
FI - Finlandia 142
UA - Ucraina 104
RU - Federazione Russa 68
GB - Regno Unito 49
BG - Bulgaria 33
IE - Irlanda 33
NL - Olanda 31
TG - Togo 31
BE - Belgio 21
AR - Argentina 20
FR - Francia 19
CA - Canada 18
RO - Romania 16
BD - Bangladesh 14
JP - Giappone 12
AT - Austria 10
CH - Svizzera 10
ID - Indonesia 10
SA - Arabia Saudita 10
IQ - Iraq 9
MA - Marocco 9
MX - Messico 9
TR - Turchia 9
UZ - Uzbekistan 9
VN - Vietnam 8
PK - Pakistan 7
AU - Australia 5
ES - Italia 4
MY - Malesia 4
NP - Nepal 4
AZ - Azerbaigian 3
IR - Iran 3
KE - Kenya 3
LV - Lettonia 3
PL - Polonia 3
PY - Paraguay 3
VE - Venezuela 3
ZA - Sudafrica 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BZ - Belize 2
CZ - Repubblica Ceca 2
EE - Estonia 2
EG - Egitto 2
GR - Grecia 2
JO - Giordania 2
KG - Kirghizistan 2
KR - Corea 2
KY - Cayman, isole 2
KZ - Kazakistan 2
LT - Lituania 2
PA - Panama 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
BJ - Benin 1
BO - Bolivia 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
EC - Ecuador 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
MK - Macedonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
RS - Serbia 1
Totale 6.118
Città #
Fairfield 454
Singapore 354
Chandler 270
Hong Kong 252
Woodbridge 236
Ashburn 218
Seattle 166
Houston 154
Ann Arbor 146
Cambridge 145
Rome 140
Wilmington 122
Princeton 89
Dearborn 87
San Paolo di Civitate 78
Santa Clara 77
Munich 73
Beijing 72
Plano 70
Lawrence 56
San Diego 41
Boston 39
Milan 39
Turku 39
Helsinki 36
Millbury 36
Los Angeles 35
Jacksonville 34
Dublin 33
Sofia 33
Bremen 32
Frankfurt am Main 32
Lomé 31
Moscow 23
Brussels 21
New York 20
Andover 19
Fremont 19
Des Moines 18
Norwalk 18
Cosenza 17
Riverside 16
Boardman 14
São Paulo 14
Federal 13
Toronto 13
Nuremberg 12
Falkenstein 10
Maserada Sul Piave 10
San Mateo 10
Jakarta 9
Kunming 9
Lendinara 9
London 9
Tokyo 9
Dallas 8
Falls Church 8
Phoenix 8
Tashkent 8
Bühl 7
Catania 7
Pune 7
The Dalles 7
Yubileyny 7
Mannheim 6
Nanjing 6
Southend 6
Basel 5
Bengaluru 5
Columbus 5
Istanbul 5
Porto Alegre 5
San Jose 5
Belo Horizonte 4
Campinas 4
Dhaka 4
Hebei 4
Jeddah 4
Lahore 4
Nanchang 4
Ottawa 4
Baghdad 3
Baku 3
Brasília 3
Brooklyn 3
Civitavecchia 3
Curitiba 3
Guangzhou 3
Gunzenhausen 3
Hangzhou 3
Hanoi 3
Hefei 3
Ho Chi Minh City 3
Manassas 3
Maricá 3
Nairobi 3
New Delhi 3
Osaka 3
Paris 3
Parma 3
Totale 4.235
Nome #
The sex-specific detrimental effect of diabetes and gender-related factors on pre-admission medication adherence among patients hospitalized for ischemic heart disease: insights from EVA study 229
L’attività ossidante dei monociti circolanti è aumentata in pazienti con diabete di tipo 2 e disfunzione erettile. 177
No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial 130
Comment on Elangovan H et al. Vitamin D in liver disease: Current evidence and potential directions. Biochim Biophys Acta 2017;1863(4):907-916 130
Screening of endocrine organ-specific humoral autoimmunity in 47,XXY Klinefelter's syndrome reveals a significant increase in diabetes-specific immunoreactivity in comparison with healthy control men. 119
Antioxidant treatment associated to sildenafil reduces monocyte activation an markers of endothelial damage in patients with diabetes and erectyle dysfunction. 118
Autoantibody negative new onset type 1 diabetic patients lacking high risk HLA alleles in a Caucasian population: are these Type 1b diabetes cases? 116
Tyrosine phosphatase-related islet antigen 2(256-760) autoantibodies, the only marker of islet autoimmunity that increases by increasing the degree of BMI in obese subjects with type 2 diabetes 114
Screening for type 1 diabetes-, thyroid-, gastric-, and adrenal-specific humoral autoimmunity in 529 children and adolescents with celiac disease at diagnosis identifies as positive one in every nine patients 113
Association of TCF7L2 gene variants with low GAD autoantibody titre in LADA subjects (NIRAD Study 5) 112
First Salivary Screening of Celiac Disease by Detection of Anti-transglutaminase Autoantibody Radioimmunoassay in 5000 Italian Primary Schoolchildren 110
Circulating monocyte oxidative activity is increased in patients with type 2 diabetes and erectile dysfunction 109
A report on the international tranglutaminase autoantibody workshop for celiac disease 108
Evidence of increased humoral endocrine organ-specific autoimmunity in severe and classic X-chromosome aneuploidies in comparison with 46,XY control subjects 105
Anti-transglutaminase immunoreactivity and histological lesions of the duodenum in coeliac patients 105
Long-standing type 1 diabetes: Patients with adult-onset develop celiac-specific immunoreactivity more frequently than patients with childhood-onset diabetes, in a disease duration-dependent manner 102
Testosterone-to-estradiol ratio and platelet thromboxane release in ischemic heart disease: the EVA project 100
Antioxidant treatment associated to sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study 99
I-123-interleukin-2 scintigraphy: A new approach to assess disease activity in autoimmunity 96
Neuroelectrophysiological alterations and autoimmunity markers in type 2 diabetes mellitus. 92
A new solid-phase radioimmunoassay to detect anti-GAD65 autoantibodies 90
Autoantigens in type 1 diabetes mellitus. 89
Anti-ganglioside antibodies in new onset type 1 diabetic patients and high risk subjects 87
GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6). 87
HLA-DQB1*02 dose effect on RIA anti-tissue transglutaminase autoantibody levels and clinicopathological expressivity of celiac disease 85
Tissue transglutaminase autoantibody detection in human saliva: a powerful method for celiac disease screening 82
Autoimmune markers and neurological complications in non-insulin-dependent diabetes mellitus. 81
Circulating levels of fetuin-A are associated with moderate–severe hepatic steatosis in young adults 79
Autoantibodies to the GM2-1 islet ganglioside and to GAD-65 at type 1 diabetes onset 78
Zinc Transporter 8 Antibodies Complement GAD and IA-2 Antibodies in the Identification and Characterization of Adult-Onset Autoimmune Diabetes Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4 77
L’attivita’ ossidante dei monociti circolanti e’ aumentata in pazienti diabetici con disfunzione erettile 77
Evidence of diabetes-specific autoimmunity in obese subjects with normal glucose tolerance 77
Humoral and cellular immune abnormalities in neonates of diabetic mothers: any pathological role? 77
GAD and IA-2 autoantibody detection in type 1 diabetic patient saliva 75
High Prevalence of Autoimmune Diabetes and Poor Glycaemic Control among Adults in Madagascar: A Brief Report from a Humanitarian Health Campaign in Ambanja 75
IgA Anti-transglutaminase Autoantibodies at Type 1 Diabetes Onset Are Less Frequent in Adult Patients and Are Associated With a General Celiac-Specific Lower Immune Response in Comparison With Nondiabetic Celiac Patients at Diagnosis 73
ANTI-TRANSGLUTAMINASE AB, TARGET DOMAINS IMMUNOREACTIVITY AND DUODENAL LESIONS IN COELIAC PATIENTS. 73
Type 1 diabetes, thyroid, gastric and adrenal humoral autoantibodies are present altogether in almost one third of adult celiac patients at diagnosis, with a higher frequency than children and adolescent celiac patients 73
COELIAC DISEASE FOLLOW-UP IN PRIMARY SCHOOL-CHILDREN DETECTED BY SALIVARY TEST. PRELIMINARY RESULTS OF THE STUDY PERFORMED IN 5000 SIX/EIGHT-YEAR SCHOLARS 72
Anti-Müllerian hormone as marker of ovarian reserve in patients with long-standing type 1 diabetes 72
Insulin prophylaxis down-regulates islet antigen expression and islet autoimmunity in the low-dose STZ mouse model of diabetes 70
Treatment of diabetic pregnant women with monocomponent insulins. 70
Markers di autoimmunità e complicanze neurologiche nel diabete di tipo 2. 69
Non-organ-specific autoimmunity in adult 47,XXY Klinefelter patients and higher-grade X-chromosome aneuploidies 69
Gluten-free diet impact on dynamics of pancreatic islet-specific autoimmunity detected at celiac disease diagnosis 68
Fasting neurotensin levels in pediatric celiac disease compared with a control cohort 68
null 68
The Celiac Iceberg in Italy: Exploring Primary School Children by RIA Salivary Anti-Transglutaminase Antibodies 67
Detection of four diabetes specific autoantibodies in a single radioimmunoassay: An innovative high-throughput approach for autoimmune diabetes screening 67
AT COELIAC DISEASE DIAGNOSIS DISTINCT TRANSGLUTAMINASE AUTOANTIBODY TARGET DOMAINS CHARACTERIZE ATYPICAL RESPECT TO TYPICAL AND SILENT COELIAC PATIENTS 66
The common PPAR-gamma 2 Pro12Ala variant is associated with greater insulin sensitivity 65
null 64
Ganglioside antigens in autoimmune diabetes 63
Rat pancreatic ganglioside expression: differences between a model of autoimmune islet B cell destruction and a normal strain. 63
Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: The non-insulin requiring autoimmune diabetes (NIRAD) study 2 62
High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7) 61
Autoimmunity markers and neurological complication in type 2 diabetes. 58
GAD and IA-2 immunoreactivity in type 1 diabetic patient saliva 58
High prevalence of autoimmunity in adult onset diabetes subjects with high GADA titre 57
High GADA titre: a marker of insulin dependence in adult onset autoimmune diabetes 56
The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults - Non Insulin Requiring Autoimmune Diabetes (NIRAD) study 3 56
Insulin-anti-insulin complexes in diabetic women and their neonates. 55
The Celiac Iceberg: Characterization of the Disease in Primary Schoolchildren 54
IS THE MUCOSAL INVOLVEMENT IN CELIAC DISEASE CONFINED TO THE DUODENUM? EVALUATION OF GASTRIC MUCOSA IN CHILDREN 53
Radioimmunological detection of anti-transglutaminase autoantibodies in human saliva: a useful test to monitor coeliac desease follow up 52
Identification of two subtypes of adult-onset autoimmune diabetes (the NIRAD Study) 47
Importance of gluten in the induction of endocrine autoantibodies and organ dysfunction in adolescent celiac patients 46
Endoscopic and Histological Gastric Lesions in Children With Celiac Disease: Mucosal Involvement Is Not Only Confined to the Duodenum 46
No effects of COVID-19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS-CoV-2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects 44
Pancreatic gangliosides delay the onset of insulitis and hyperglycaemia in the low-dose streptozotocin mouse model. 43
Ridotta risposta immune celiaco-specifica nei pazienti con diabete di tipo 1 all’esordio e celiachia, rispetto ai celiaci non diabetici alla diagnosi 43
Autoimmunity and obesity in children and young adolescents 41
Sera from diabetic pregnant women contain reduced titres of inhibiting factors on killer cell activity. 39
Adult-onset autoimmune diabetes: identification of a new marker for the detection of anti-tyrosine phosphatase 2 (IA-2) antibodies (The NIRAD Study) 39
Obesity in the Youth Is Associated with Islet Cell Autoimmunity 38
How Valuable Is "10-Time ULN Threshold" for Identifying Villous Atrophy in Screening-Detected Patients? 37
An electrochemical immunoassay for the screening of celiac disease in saliva samples 37
Immunoreactivities Against Different Tyrosine-Phosphatase 2 (IA-2)(256-760) Protein Domains Characterize Distinct Phenotypes in Subjects With LADA 36
La malattia celiaca. Malattia “immaginaria” o misconosciuta? Una finestra sull’attualità. 35
Investigating the Relationship Between COVID-19 and Celiac Disease. A Dual Research Approach 31
Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification of adult-onset autoimmune diabetes 27
null 26
null 26
null 25
IA-2 combined epitope assay: a new, highly sensitive approach to evaluate IA-2 humoral autoimmunity in type 1 diabetes 23
Neurotensin: any clue in pediatric celiac disease? 23
Correction to: No effects of COVID‑19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS‑CoV‑2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects 21
Pandora's Box: Coeliac Disease Among First-Degree Relatives of Screening-Detected Celiac Patients 19
Totale 6.314
Categoria #
all - tutte 19.289
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.289


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021430 45 42 16 36 16 37 21 34 61 50 65 7
2021/2022826 12 52 84 40 100 20 26 68 62 62 159 141
2022/2023941 168 224 52 105 94 96 23 49 88 5 29 8
2023/2024382 27 51 21 34 31 64 7 28 7 48 33 31
2024/20251.663 62 94 70 53 94 99 99 58 242 166 148 478
2025/2026162 162 0 0 0 0 0 0 0 0 0 0 0
Totale 6.314